Voronoi, Inc. Logo

Voronoi, Inc.

Develops selective kinase inhibitors and targeted protein degraders for precision oncology.

310210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 에스동 18층, 연수구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Voronoi, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of novel therapeutics, with a primary focus on precision medicine for oncology. The company's expertise lies in creating innovative kinase inhibitors and targeted protein degraders. Voronoi leverages its proprietary drug discovery platform, VORONOMICS™, to rapidly identify and optimize drug candidates. This platform is designed to develop therapies with high selectivity and the ability to penetrate the brain barrier. Its pipeline includes targeted treatments for various cancers, such as non-small cell lung cancer (NSCLC) and HER2-positive solid tumors, aiming to accelerate the delivery of new therapies from design to the clinic.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
M&A Activity
투자판단관련주요경영사항 (VRN04 프로그램 연구에 대한 옵션 행사 및 자산 구매 계약 체결)
Korean 10.7 KB
2025-09-08 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 125.2 KB
2025-09-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.8 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 120.3 KB
2025-08-20 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (표피성장인자 수용체EGFR 돌연변이 비소세포폐암NSCLC 환자…
Korean 19.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-07-04 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-06-30 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 76.6 KB
2025-06-12 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-05-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-16 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-14 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (표피성장인자 수용체EGFR 돌연변이 비소세포폐암NSCLC 환자…
Korean 19.3 KB
2025-05-09 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-08 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.3 KB

Automate Your Workflow. Get a real-time feed of all Voronoi, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Voronoi, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.